BioMerieux and Hitachi High-Technologies will work together to identify and develop new systems. The new instruments developed under this partnership will be manufactured by Hitachi High-Technologies and distributed through BioMerieux’s worldwide commercial network. Teams from BioMerieux and Hitachi High-Technologies are working together toward development milestones on a new system.
Stephane Bancel, CEO of BioMerieux, said: “BioMerieux’s vision, and a key objective of our 2012 strategy, is to bring full automation to microbiology laboratories around the world. We will also introduce innovative systems to molecular diagnostics, leveraging BioMerieux’s expertise in biology and Hitachi’s remarkable engineering capabilities.”